Meng Xu
- Biochemistry top 5%
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments 5
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 12
- Pharmacology top 5%
-
- Pharmaceutical studies and practices 12
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Health Systems, Economic Evaluations, Quality of Life 5
-
- SARS-CoV-2 and COVID-19 Research 5
-
- Ubiquitin and proteasome pathways 4
-
- COVID-19 Impact on Reproduction 4
- Co-authors
- Chandrasekhar UdataArie KatzGuodong ZhengO. VesterqvistMichael E. BurczynskiLisa HickeyElyssa OttXuebo Liu
- Journals
- European Journal of Pain (4 papers)The Journal of Clinical Pharmacology (4 papers)British Journal of Clinical Pharmacology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meng Xu
99 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 153
- Biochemistry 91
- Gastroenterology 80
- Biological Psychiatry 29
- Immunology 219
- Pharmacology 82
Countries citing papers authored by Meng Xu
This map shows the geographic impact of Meng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xu more than expected).
Fields of papers citing papers by Meng Xu
This network shows the impact of papers produced by Meng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xu. The network helps show where Meng Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 19 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 111 | |
| 16 | 2020 | 1 | |
| 17 | 2014 | 2 | |
| 18 | Comparative Study of Micro-simulation Performances for Urban Road Network between Vissim and Corsim | 2012 | 0 |
| 19 | 2009 | 9 | |
| 20 | Reconfigurable Platform for Knowledge Management Based on Ontology | 2003 | 7 |
About Meng Xu
Meng Xu is a scholar working on Gastroenterology, Infectious Diseases and Obstetrics and Gynecology, having authored 109 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (12 papers), Biosimilars and Bioanalytical Methods (12 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Gastroesophageal reflux and treatments (5 papers), Ubiquitin and proteasome pathways (4 papers) and COVID-19 Impact on Reproduction (4 papers). The work is most often cited by research in Biochemistry (91 citations), Gastroenterology (80 citations) and Biological Psychiatry (29 citations). Meng Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chandrasekhar Udata, Arie Katz, Guodong Zheng, O. Vesterqvist, Michael E. Burczynski, Lisa Hickey, Elyssa Ott, Xuebo Liu, Licong Yang and Wanqiang Wu. Their work appears in journals such as European Journal of Pain, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.